Common use of Trial Data Clause in Contracts

Trial Data. During the course of the Trial, Principal Investigator will collect and submit certain data to Sponsor or its agent, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required to be submitted to Sponsor or its agent, such as X-ray, MRI, or other types of medical images, ECG, EEG, or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.1

Trial Data. During the course of the Trial, Institution and Principal Investigator will collect and submit certain data to Sponsor or its agentdesignee, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required to be submitted to Sponsor or its agentdesignee, such as X-ray, magnetic resonance imaging (“MRI”), or other types of medical images, ECG, EEG, or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.112.1.

Trial Data. During the course of the Trial, Institution and Principal Investigator will collect and submit certain data to Sponsor or its agentagent and/or INC Research, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required under the Protocol to be submitted to Sponsor or its agentagent and/or INC Research, such as X-X- ray, MRI, or other types of medical images, ECG, EEG, or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.1Institution 13.1

Trial Data. During the course of the Trial, Principal Investigator Institution will collect and submit certain data to Sponsor or its agent, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required to be submitted to Sponsor or its agent, such as X-ray, magnetic resonance imaging (“MRI”), or other types of medical images, electrocardiogram (“ECG”), electroencephalography (“EEG”), or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.1.

Trial Data. During the course of the Trial, Institution and Principal Investigator will collect and submit certain data to Sponsor or its agent, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required to be submitted to Sponsor or its agent, such as X-ray, MRI, or other types of medical images, ECG, EEG, or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.112.1

Trial Data. During the course of the Trial, Institution and Principal Investigator will collect and submit certain data to Sponsor or its agent, as specified in the Protocol. This includes CRFs (or their equivalent) or electronic data records, as well as any other documents or materials created for the Trial and required to be submitted to Sponsor or its agent, such as X-ray, MRI, or other types of medical images, ECG, EEG, or other types of tracings or printouts, or data summaries (collectively, “Trial Data”). Principal Investigator will ensure accurate and timely collection, recording, and submission of Trial Data. 11.1be